Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Relations between approved platinum drugs and non-coding RNAs in mesothelioma.

Biersack B.

Noncoding RNA Res. 2018 Aug 30;3(4):161-173. doi: 10.1016/j.ncrna.2018.08.001. eCollection 2018 Dec. Review.

2.

3,3'-Diindolylmethane ameliorates renal fibrosis through the inhibition of renal fibroblast activation in vivo and in vitro.

Xia ZE, Xi JL, Shi L.

Ren Fail. 2018 Nov;40(1):447-454. doi: 10.1080/0886022X.2018.1490322.

3.

Inhibitory effect of the low-toxic exogenous aryl hydrocarbon receptor modulator 3'3-diindolylmethane on gastric cancer in mice.

Su M, Qian C, Hu Y, Lu W, Huang R, Chen M, Chen J.

Oncol Lett. 2017 Dec;14(6):8100-8105. doi: 10.3892/ol.2017.7185. Epub 2017 Oct 16.

4.

Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.

Boakye CHA, Patel K, Doddapaneni R, Bagde A, Behl G, Chowdhury N, Safe S, Singh M.

Colloids Surf B Biointerfaces. 2016 Jul 1;143:156-167. doi: 10.1016/j.colsurfb.2016.03.036. Epub 2016 Mar 15.

5.
6.

Attenuation of hyperglycemia-mediated oxidative stress by indole-3-carbinol and its metabolite 3, 3'- diindolylmethane in C57BL/6J mice.

Jayakumar P, Pugalendi KV, Sankaran M.

J Physiol Biochem. 2014 Jun;70(2):525-34. doi: 10.1007/s13105-014-0332-5. Epub 2014 Apr 9.

PMID:
24715233
7.

Development and validation of an HPLC method for the simultaneous quantification of indole-3-carbinol acetate, indole-3-carbinol, and 3,3'-diindolylmethane in mouse plasma, liver, and kidney tissues.

Moussata J, Wang Z, Wang J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 May 1;958:1-9. doi: 10.1016/j.jchromb.2014.02.026. Epub 2014 Mar 12.

PMID:
24686233
8.

Regulation of carbohydrate metabolism by indole-3-carbinol and its metabolite 3,3'-diindolylmethane in high-fat diet-induced C57BL/6J mice.

Poornima J, Mirunalini S.

Mol Cell Biochem. 2014 Jan;385(1-2):7-15. doi: 10.1007/s11010-013-1808-2. Epub 2013 Sep 27.

PMID:
24072613
9.

Structural elaboration of a natural product: identification of 3,3'-diindolylmethane aminophosphonate and urea derivatives as potent anticancer agents.

Kandekar S, Preet R, Kashyap M, Renu Prasad MU, Mohapatra P, Das D, Satapathy SR, Siddharth S, Jain V, Choudhuri M, Kundu CN, Guchhait SK, Bharatam PV.

ChemMedChem. 2013 Nov;8(11):1873-84. doi: 10.1002/cmdc.201300273. Epub 2013 Aug 28.

PMID:
23983049
10.

Effect of diindolylmethane on Ca(2+) homeostasis and viability in MDCK renal tubular cells.

Fang YC, Chou CT, Chi CC, Lin KL, Li YD, Cheng HH, Lu YC, Cheng JS, Kuo CC, Jan CR.

Hum Exp Toxicol. 2013 Apr;32(4):344-53. doi: 10.1177/0960327112462727.

PMID:
23613483
11.

In vivo and in vitro study on the role of 3,3'-diindolylmethane in treatment and prevention of nasopharyngeal carcinoma.

Chen C, Chen SM, Xu B, Chen Z, Wang F, Ren J, Xu Y, Wang Y, Xiao BK, Tao ZZ.

Carcinogenesis. 2013 Aug;34(8):1815-21. doi: 10.1093/carcin/bgt122. Epub 2013 Apr 8.

PMID:
23568953
12.

BreastDefendā„¢ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer.

Jiang J, Thyagarajan-Sahu A, Loganathan J, Eliaz I, Terry C, Sandusky GE, Sliva D.

Oncol Rep. 2012 Oct;28(4):1139-45. doi: 10.3892/or.2012.1936. Epub 2012 Jul 26.

13.

The potential efficacy of 3,3'-diindolylmethane in prevention of prostate cancer development.

Fares F, Azzam N, Appel B, Fares B, Stein A.

Eur J Cancer Prev. 2010 May;19(3):199-203. doi: 10.1097/CEJ.0b013e328333fbce.

PMID:
20010430
14.

A controlled safety study of diindolylmethane in the immature rat model.

Elackattu AP, Feng L, Wang Z.

Laryngoscope. 2009 Sep;119(9):1803-8. doi: 10.1002/lary.20526.

15.

Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450.

Crowell JA, Page JG, Levine BS, Tomlinson MJ, Hebert CD.

Toxicol Appl Pharmacol. 2006 Mar 1;211(2):115-23. Epub 2005 Jul 25.

PMID:
16043203
16.

Therapeutic activity of 3,3'-diindolylmethane on prostate cancer in an in vivo model.

Nachshon-Kedmi M, Fares FA, Yannai S.

Prostate. 2004 Oct 1;61(2):153-60.

PMID:
15305338
17.

Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice.

Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, Farmer PB, Steward WP, Williams ML.

Clin Cancer Res. 2004 Aug 1;10(15):5233-41.

18.

Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice.

Anderton MJ, Manson MM, Verschoyle R, Gescher A, Steward WP, Williams ML, Mager DE.

Drug Metab Dispos. 2004 Jun;32(6):632-8.

PMID:
15155555
19.
20.

Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats.

Stresser DM, Williams DE, Griffin DA, Bailey GS.

Drug Metab Dispos. 1995 Sep;23(9):965-75.

PMID:
8565787

Supplemental Content

Loading ...
Support Center